AIDS Vaccine Development
- Introduction
- The Global HIV/AIDS Epidemic
- Biology of Early Infection and Impact on Vaccine Design
- CTL-Based Vaccines: Evidence for Efficacy in Animal Models and Humans
- What Does A Vaccine Need to Do to Elicit Protective Immunity Against HIV Infection?
- Antigen Selection and the Design of an AIDS Vaccine
- Broadly Neutralizing Antibodies and a Vaccine for HIV
- Vaccines that Induce Cellular Immunity
- Alternate Routes on the Roadmap to an HIV Vaccine: Importance of Innate and Adaptive Mucosal Immunity
- HIV Subtypes, Antigenic Diversity, and Vaccine Design
- The HIV Vaccine Pipeline
- Clinical Site Development and Preparation for AIDS Vaccine Efficacy Trials in Developing Countries
- Issues in the Design of HIV Vaccine Efficacy Trials
- Lessons from the AIDSVAX B/B' Vaccine Efficacy Trial
- The Thai VaxGen Trial: What Have We learned?
- Regulatory Issues for AIDS Vaccine Development
- Vaccine Scale-Up and Manufacturing
- Global Access to Vaccines: Deployment, Use and Acceptance
- The Potential Public Health Impact of Imperfect HIV-1 Vaccines
- AIDS Vaccine Development
